118 related articles for article (PubMed ID: 37138487)
1. Chinese Medicine Supplementing Qi and Activating Blood Circulation Relieves the Progression of Diabetic Cardiomyopathy.
Tong R; Wu T; Chen J
Endocr Metab Immune Disord Drug Targets; 2024; 24(1):163-171. PubMed ID: 37138487
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
3. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
4. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
5. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
6. Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats.
Liu Y; Qi H; Wang Y; Wu M; Cao Y; Huang W; Li L; Ji Z; Sun H
Phytomedicine; 2012 Jun; 19(8-9):693-8. PubMed ID: 22633288
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effect of combined use of FGF1-loaded nano-liposomes and ultrasound-targeted microbubble destruction technique on treating rats with experimental diabetic cardiomyopathy].
Zhang M; Zhao YZ; Ma WC; Xu JL; Wang JL; Chen MJ; Yu L; Chen YN
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May; 45(5):427-433. PubMed ID: 28511329
[No Abstract] [Full Text] [Related]
8. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
Li B; Zheng Z; Wei Y; Wang M; Peng J; Kang T; Huang X; Xiao J; Li Y; Li Z
Cardiovasc Diabetol; 2011 Jul; 10():69. PubMed ID: 21798071
[TBL] [Abstract][Full Text] [Related]
9. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
[TBL] [Abstract][Full Text] [Related]
11. [Berberine inhibits cardiac fibrosis of diabetic rats].
Lu K; Shen Y; He J; Liu G; Song W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1352-1355. PubMed ID: 27667461
[TBL] [Abstract][Full Text] [Related]
12. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
[TBL] [Abstract][Full Text] [Related]
13. Losartan reduces myocardial interstitial fibrosis in diabetic cardiomyopathy rats by inhibiting JAK/STAT signaling pathway.
Wang L; Li J; Li D
Int J Clin Exp Pathol; 2015; 8(1):466-73. PubMed ID: 25755735
[TBL] [Abstract][Full Text] [Related]
14. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
Yue Y; Meng K; Pu Y; Zhang X
Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
[TBL] [Abstract][Full Text] [Related]
16. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling.
Meng S; Yang F; Wang Y; Qin Y; Xian H; Che H; Wang L
Cell Biol Int; 2019 Jan; 43(1):65-72. PubMed ID: 30489003
[TBL] [Abstract][Full Text] [Related]
17. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
19. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
Wang L; Shi H; Huang JL; Xu S; Liu PP
Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
